Bloomberg Law
December 2, 2017, 1:14 PM UTC

Lance Armstrong Trial Could Have Landis, Nike Confrontations

Daniel Seiden

Lance Armstrong may ask former cyclist teammate Floyd Landis about performance-enhancing drug (PED) use by other cyclists during next year’s false claims trial against Armstrong, but attacks on Landis’s character aren’t permitted, the U.S. District Court for the District of Columbia ruled (United States ex rel. Landis v. Tailwind Sports Corp., D.D.C., No. 10-976, 11/28/17).

Armstrong also blocked the government from arguing at trial, set to start in May, that negative publicity from drug use outweighed the benefits of a sponsorship agreement between Armstrong and the U.S. Postal Service, the court said.

However, the government will be allowed ...

Learn more about Bloomberg Law or Log In to keep reading:

Learn About Bloomberg Law

AI-powered legal analytics, workflow tools and premium legal & business news.

Already a subscriber?

Log in to keep reading or access research tools.